At a glance
ClinicalIndex Comparison RecordPhase 2Completed
Drug / intervention
INO-1001drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase II Randomized, Placebo-Controlled, Single-Blind, Multi-Center Dose-Escalation Study to Evaluate Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of a Single Intravenous Administration of INO-1001 in Subjects With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
In Brief
A Phase 2 clinical trial evaluating INO-1001 for Acute Myocardial Infarction. Completed, across 16 sites in 2 countries.
Detailed Summary
The primary purpose of this study is to assess the safety of INO-1001 in subjects who have experienced a heart attack and are to be treated with coronary angioplasty.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Myocardial Infarction
CountriesIsrael, United States
Collaborators--
Timeline
Phase 2CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 2004
First PostedJan 2006
Study CompletionJun 2006
TodayJul 2026
First PostedJan 4, 2006
Enrollment StartJan 1, 2004
Study CompletionJun 1, 2006
TodayJul 2, 2026
Posted 20.5 years ago
Interventions
INO-1001drug